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Trichinella spiralis is an intracellular nematode parasite of mammalian skeletal 
muscle.  Infection of the muscle cell leads to the formation of a host-parasite 
complex that results in profound alterations to the host cell and a re-alignment of 
muscle-specific gene expression.  The role of parasite excretory-secretory (ES) 
proteins in mediating these effects is currently unknown, largely due to the 
difficulty in identifying and assigning function to individual proteins.  In this 
study, a global proteomics approach was used to analyse the ES proteins from T. 
spiralis muscle larvae.  Following 2-dimensional electrophoresis (2-DE) of ES 
proteins, matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF)-
mass spectrometry and liquid chromatography tandem mass spectrometry (LC-
MS/MS) were used to identify the peptide spots.  Specific Trichinella EST 
databases were assembled and used to analyse the data.  Despite the current 
absence of a Trichinella genome-sequencing project, 43 out of 52 protein spots 
analysed were identified and included the major secreted glycoproteins. Other 
novel proteins were identified from matches with sequences in the T. spiralis 
database.  Our results demonstrate the value of proteomics as a tool for the 
identification of Trichinella ES proteins and in the study of the molecular 





1  Introduction 
Profound alterations in skeletal muscle can occur as a result of injury, disease or 
infection with pathogens.  One of the most extreme cases is observed in cells 
infected with the nematode parasite, Trichinella spiralis, an intracellular parasite 
specific for mammalian skeletal muscle.  The newborn L1 larva migrates from 
the intestine of the host to the skeletal muscle where it infects and encapsulates 
within a portion of the myofiber and develops into the infective or muscle L1 
larva [1].  During this process an intimate host-parasite complex, the nurse cell, 
is formed.  Infection of the terminally-differentiated cell by T. spiralis leads to 
profound changes, including re-entry into the cell cycle with subsequent 
suspension at the G2/M border, down-regulation of muscle-specific gene [2] and 
muscle-specific protein [3] expression, dissolution of myofibrils, proliferation of 
secretory organelles and nuclear enlargement [4].  These changes to the infected 
muscle cell suggest that the differentiated state in the skeletal muscle cell is 
repressed and that post-infection a process of de-differentiation is initiated.  This 
is followed by re-differentiation into an alternative cell type, one that is adapted 
to support the parasite until its transmission to the next host.  The molecular 
mechanisms underlying the re-programming of the skeletal muscle are currently 
unknown although there is circumstantial evidence implicates larval excretory-
secretory (ES) proteins in the formation and/or maintenance of the nurse cell.  ES 
proteins collected from both newborn larvae and muscle larvae elicit 
morphological and structural changes to cultured primary rat myocytes [5].  
Furthermore, antigens sharing epitopes with secreted Trichinella proteins have 
been detected within isolated host cell nuclei where they co-localise with nuclear 
chromatin complexes [6, 7, 8].  However, the abundance of these proteins has 
been too low to allow identification and therefore confirmation of the parasite 
origin of these antigens awaits data connecting them to Trichinella-encoded 
genes.  Although several biochemical activities have been observed in the 
Trichinella ES fraction, including DNA-binding [9], DNA endonuclease [10, 
11], protease [12, 13] and kinase activities [14, 15], relatively few of the proteins 
responsible or the genes encoding them have been characterised to date.   
 
The identification and characterisation of ES proteins is of fundamental 
importance to understanding the mechanism of parasite-induced de-
differentiation.  Recently, mass spectrometric analysis has led to the identification 
of two ES proteins, a 67 kDa 5'-nucleotidase [16] and a putative serine protease 
[17].  This suggests that the application of proteomics may circumvent many of 
the problems encountered with the identification of ES proteins in the past.  
Proteomic analysis has been successfully used to identify ES proteins from other 
helminth parasites such as the nematode Haemonchus contortus [18] and the 
trematode Fasciola hepatica [19, 20].  In the current study, we have used data 
collected from 2-DE and mass spectrometry (MS) to analyse and identify the ES 
proteins from T. spiralis muscle larvae.  This represents the first study which 
attempts to comprehensively identify Trichinella ES proteins and, as such, will 
provide valuable information for further studies.   
 
2  Materials & Methods 
 
2.1  Parasites 
T. spiralis (ISS390) parasites were maintained in female ICR/CD1 mice and 
muscle larvae were isolated from infected mice as previously described [21]. 
 
2.2  Collection and preparation of ES proteins 
Isolated T. spiralis muscle larvae were washed several times in pre-warmed RPMI 
1640 medium (Invitrogen) and resuspended at 5000 muscle larvae ml-1 in RPMI 
containing 2 mM L-glutamine, 100 U ml-1 penicillin, 100 g ml-1 streptomycin.  
The parasites were maintained at 37C  / 5% CO2 for up to 20 h after which the 
larvae were allowed to sediment and the culture medium containing the ES 
protein was collected [22].  Where necessary, the larvae were resuspended in fresh 
culture medium and incubated for a further 20 h under the same conditions.  ES 
proteins were concentrated from the culture supernatants by precipitation with 
methanol / chloroform [23].  Normally, 400 l of culture supernatant was used for 
1-DE and 1.6 ml for 2-DE, although volumes were adjusted to ensure equal 
loading between successive gels.  Protein samples were resuspended in buffer 
(100 mM Tris-HCl, pH 6.8, 200 mM DTT, 4% SDS, 20% glycerol) prior to 1-DE 
or re-swelling buffer (7 M urea, 4% CHAPS, 2 M thio-urea, 0.3%  DTT, 2% 
resolyte ampholytes pH 4-7) prior to 2-DE.   
 
2.3  De-glycosylation of ES proteins 
ES proteins were de-glycosylated using PNGase F (New England Biolabs) 
according to the manufacturer’s instructions.  Briefly, precipitated ES proteins 
were resuspended in 80 l 1X denaturation buffer (supplied with enzyme) and 
heated to 95C for 10 mins.  Following denaturation 8 l NP-40, 8 l G7 buffer 
(supplied with enzyme) and 5 l PNGase F were added and the samples incubated 
at 37C overnight.  The control sample was identical except for the omission of 
PNGase F.  The ES proteins were then precipitated as above and resuspended in 
an appropriate buffer for electrophoresis.   
 
2.4  1-D and 2-D electrophoresis 
ES protein samples were analysed by 1-DE using NuPage® Novex® 4-12% Bis-
Tris gels (Invitrogen) and NuPage® LDS sample buffer plus Sample Reducing 
Agent (Invitrogen) were added to the samples prior to electrophoresis.  1-DE 
analysis was also used to equalise ES protein samples prior to 2-DE.  For 2-DE, 
the ES protein samples were loaded onto pH 4-7 IPG strips (Amersham 
Biosciences) for separation in the first dimension.  The samples were re-hydrated 
overnight at room temperature followed by step voltage focussing (0.01 h 200 V; 
1.5 h 3500 V; 1.05 h 3500 V) at 22C and the strips were incubated in 7mls of 
equilibrating buffer (50 mM Tris, 6 M Urea, 30% glycerol, 2%  SDS) containing 
10 mg ml-1 DTT for 30 min.  Following this, a further equilibration step was 
performed with equilibrating buffer containing 25 mg ml-1 iodoacetamide for 30 
min.  For separation in the second dimension, the IPG strips were laid on 10-15% 
non-linear gradient polyacrylamide gels and run at 75 V for 1 h and then at 150 V 
until 140 volt-hours were reached.  After separation, proteins were visualised by 
staining with Colloidal Coomassie Blue G250 (Sigma) as described elsewhere 
[24]. 
 
2.5  Immunoblotting 
ES proteins separated by 1-DE and 2-DE were transferred to Hybond-C pure 
nitrocellulose membranes (Amersham Biosciences) using a Novex XCell 
Surelock Mini-Cell blot module apparatus (Invitrogen) for 1 h at 30 V.  
Following transfer, the membranes were incubated in blocking solution (TSBT: 
20 mM Tris-HCl, 150 mM NaCl, 1% Tween-20, pH 7.6) containing 5% skimmed 
milk for 3 h at room temperature.  Primary antibody (mAb 18H) was diluted 
1:1500 in TBST containing 1% skimmed milk and applied to the membranes 
overnight at 4C.  After washing in TBST (4 X 10 min), the anti-mouse-IgG 
secondary antibody conjugated to alkaline phosphatase (Sigma) was applied at a 
dilution of 1:10000 in TBST for 1 h.  The blots were developed using 5-bromo-4-
chloro-3-indolyl phosphate / nitro blue tetrazolium substrate (Sigma).   
 
2.6  Mass Spectrometry 
MALDI-TOF-MS was performed at the University of Aberdeen Promteome 
Facility using a protocol adapted from a published method [25].  Briefly, protein 
spots were excised from the stained 2-D gels and subjected to in-gel proteolytic 
digestion with trypsin (Sigma) using an Investigator ProGest instrument 
(Genomic Solutions).  The resulting tryptic fragments were guanidylated with 
methylisourea, desalted and concentrated using an Investigator ProMS 
instrument (Genomic Solutions) before analysis using a PerSpective Biosystems 
Voyager-DE STR MALDI-TOF mass spectrometer, operating in reflectron mode 
at 20 kV accelerating voltage.  Spectra were internally calibrated using trypsin 
autodigestion products.  LC-MS/MS was performed at the Sir Henry Wellcome 
Functional Genomics Facility, University of Glasgow.  After in-gel tryptic 
digestion, the resulting peptides were solubilized in 0.5 % formic acid and 
fractionated by nanoflow HPLC on a C18 reverse phase column, eluting with a 
continuous linear gradient to 40% acetonitrile over 20 minutes.  The eluate was 
analysed by online electrospray tandem MS using a Qstar Pulsar instrument 
(Applied Biosystems).  A 3-second survey scan preceded each MS/MS data 
collection cycle of four 3-second product ion scans, giving a duty cycle of 15 
seconds.  For tandem MS performed by the FingerPrints Proteomics Facility, 
University of Dundee, tryptic peptides were analysed on an Applied Biosystems 
4700 Proteomics Analyser (MALDI-TOF-TOF-MS-MS system) in MS reflector 
mode to generate a peptide mass fingerprint (PMF).  Five of the most intense 
peptide ions were selected for further analysis by MS/MS.  The MS and MS/MS 
data were combined and used by the Applied Biosystems GPS system (Global 
Proteomics Server) and MASCOT (Matrix Science) to search the databases.  
 
2.7  Database searching 
The PMF profiles obtained from MALDI-TOF-MS were used to search databases, 
run locally using MS-Fit (Protein Prospector) against a custom-made Trichinella 
EST database and the NemaCluster database for Trichinella [26].  The following 
parameters were used: methionine oxidation, cysteine carbamidomethylation and 
lysine guanidylation.  The peptide mass tolerance was initially set at 50 ppm but 
was increased to 150 ppm when searching EST databases.  Similarly, up to 3 
missed cleavages were allowed when searching EST databases.  Searches were 
also carried out against all mouse sequences in the NCBInr database in order to 
identify potential host proteins.  Database searches using LC-MS/MS data were 
carried out using MASCOT (Matrix Science). 
 
3  Results 
 
3.1 2-DE analysis of Trichinella ES proteins 
ES proteins secreted by isolated T. spiralis muscle larvae during in vitro 
cultivation were precipitated from culture supernatants collected following 6 h, 20 
h and 40 h incubation in RPMI medium and analysed by 2-DE (Fig. 1A-C).  The 
most prominent ES proteins in the 6 h sample migrated in the 40-60 kDa range.  
These corresponded to the major glycosylated proteins in the 40 h ES sample as 
shown by Western blotting and immuno-analysis with mAb 18H, a monoclonal 
antibody that is specific for tyvelose-containing glycans epitopes [27] found on 
some Trichinella ES proteins (Fig 1D).  This was consistent with previous 
observations that the major immuno-dominant ES proteins of the T. spiralis 
muscle larva are glycosylated and in this size range [28, 29, 30].  Following later 
cultivation times, both the number of protein spots and the overall complexity of 
the ES profile increased, notably in the lower molecular mass range (ie 15-40 
kDa).  The 2-DE profiles shown are representative of T. spiralis ES proteins and 
gel-to-gel reproducibility was very high between independent samples (for 
example, compare Fig. 1C and Fig. 2).   
 
3.2 Identification of Proteins by 2-DE and Mass Spectrometry 
 
Using the current sample preparation method and pH range, approximately 125 
Coomassie Blue-stained spots were visible on 2-D gels of T. spiralis 40 h ES 
proteins (Fig. 1C).  In order to identify the major ES proteins, a total of 52 
different prominent spots were excised from 2-D gels (Fig 2) and a proteomic 
analysis of selected spots was carried out using MALDI-TOF-MS.  The resulting 
PMF data were used to search databases.  As relatively few Trichinella sequences 
are available in the public cDNA and protein databases, searches using these were 
largely unsuccessful.  Consequently, a custom-made database was compiled from 
all Trichinella sequences, both cDNA and EST, deposited in GenBank.  Latterly, 
the Trichinella EST cluster database compiled as part of the Parasitic Nematode 
EST project [26] was also used for searches.  In line with other studies, a match to 
a Trichinella protein was considered significant where there were at least 5 
matched peptides and 15% coverage of the protein sequence [31].  For matches to 
ESTs, fewer peptide matches and a lower percent coverage were tolerated in 
making a putative assignment of protein identity.  Other criteria used to assign 
spots to proteins included matching the calculated theoretical molecular mass and 
pI values of the protein, where possible, with the observed position of the peptide 
on the 2-D gel.  Because of the limited availability of complete cDNA sequence 
data all of the spot identifications initially assigned on the basis of PMF data were 
considered tentative until confirmation could be obtained by tandem MS.  To do 
this LC-MS/MS was used to supplement the PMF data and to assign identities to 
those proteins un-identified by MALDI-TOF alone.  In these cases, searches were 
carried out using MASCOT (MatrixScience) and MOWSE scores >70 were 
considered to be significant.   
 
Using the above criteria for PMF data, positive matches to Trichinella proteins or 
ESTs were obtained for 23 peptide spots (Table 1), although in 2 cases (spots 8 
and 10) the PMF-based assignment was considered borderline. The identities of 
22 were confirmed by LC-MS/MS; spot 12 was excluded as the identification 
based on the PMF data was to a complete cDNA and was considered robust.  A 
further 20 spots were successfully identified using LC-MS/MS alone giving a 
total of 43 out of 52 Trichinella ES proteins identified using MS.  The remaining 
9 spots were un-matched to any Trichinella sequence currently in the database.  
 
The 43 significant matches corresponded to only 13 different proteins encoded by 
Trichinella cDNAs or ESTs; 4 to known T. spiralis ES proteins, 3 to predicted ES 
proteins and the remaining 6 to putative proteins encoded by novel ESTs (Table 
1).  Twelve spots (1, 8-12, 26 and 31-35), ranging in size from 44.5 to 69.0 kDa 
and with pI values ranging from 5.14 - 6.64, were assigned to a cDNA encoding 
the T. spiralis serine protease, TspSP-1 [32, 17].  The predicted size of TspSP-1 
based on the cDNA is 48 kDa, however, anti-TspSP-1 antibodies detect native 
proteins of 50, 64 and 70 kDa by 1-DE and evidence from de novo amino acid 
sequencing and tandem MS, suggests that several isoforms of the protein are 
present in the ES [17].  Two spots (2 and 7) were identified as the major secreted 
glycoprotein p43; the identification of two isoforms of this protein differing in pI 
was again consistent with previous observations [29].  A further three spots (5, 27 
and 28) were identified as the secreted 45 kDa antigen and one spot (13) was 
assigned to the secreted 5'-nucleotidase [16, 33].  In these cases, there was close 
agreement between the predicted molecular mass and pI with those observed by 2-
DE.   
 
Spots assigned to three different hypothetical Trichinella proteins were also 
identified, confirming that these proteins are expressed and secreted.  Seven spots 
(3 and 16-21) were assigned to ORF 9.10.  Spots 3 and 16 shared molecular mass 
and pI values of 48.5 kDa and 4.94 / 4.86, respectively, whilst the other ORF 9.10 
spots formed a distinct group of lower molecular mass (~35 kDa) with pI values 
in the range of 4.94 – 5.78.  Five spots (39-43) with approximate molecular mass 
of 22.5 – 24.6 kDa and pI values ranging from 4.92 – 6.39 were identified as the 
ORF 17.20 protein.  In addition, spot 46 was assigned to the ORF 11.30 protein.  
All of these are novel proteins that have yet to be characterised.  The remaining 
twelve spots were assigned to proteins encoded by Trichinella ESTs, all of which 
appeared to be novel.  Spots 45 and 49-52 were assigned to two related ESTs 
(BG353021 and BG353717), which were subsequently found on contig TS01176 
in the NemaGene database.  A complete ORF was identified within TS01176 
encoding a novel 15.7 kDa protein with a putative N-terminal signal peptide. The 
theoretical molecular mass for this protein matched that observed for this group of 
spots.  The ESTs BG520944 (spot 6), BG520575 (spots 14 and 15), BQ540916 
(spots 29 and 30) and BG345905 (spot 38) all encoded protein fragments that 
included an N-terminal signal peptide, as predicted by the SignalP algorithm [34].  
Thus 12 of the identified proteins were predicated to be secretory proteins due the 
presence of an N-terminal signal peptide.  The single exception was EST 
BQ542714 (spot 36), which encoded a protein fragment lacking the signal 
sequence though this could be due to the fact that the EST probably derives from 
a truncated cDNA lacking 5’ gene sequence information. 
 
Despite the successful identification of 43 ES proteins, a few notable exceptions 
were not identified including the 53 kDa secreted glycoprotein [35] and the 
secreted nucleoside diphosphate kinase [15].  These proteins have predicted pI 
values of 8.42 and 7.94 respectively and therefore will not resolve on the 2-D gels 
used in this study.  
 
3.3 Glycosylation of T. spiralis ES proteins 
 
The major tyvelosylated T. spiralis ES glycoproteins resolved as approximately 
30 immuno-reactive peptides following 2-DE and Western analysis with the anti-
tyvelose monoclonal Ab18H (Fig 1D).  Fifteen of these tyvelose-bearing proteins 
were identified by MS including the secreted 45 kDa antigen, glycoprotein p43 
and the TspSP-1 serine protease.  Following treatment with PNGase F, which 
cleaves N-linked glycans many ES proteins, including those not recognised by the 
mAb 18H antibody, changed position with regard to their molecular weight and pI 
(Fig 3).  Overall, there was a net movement of spots into the 30-40 kDa and 15 
kDa molecular mass regions indicating that a number of peptides had decreased in 
mass following de-glycosylation.  Therefore, a large subset of the ES proteins 
appears to be glycosylated with N-linked glycans.  These included the secreted 45 
kDa and those encoded by the ESTs BG520575, BQ540916, BG353717 and 
BG353021.  Peptide spots that did not change their position following de-
glycosylation included those identified as the ORF 9.10 protein, the secreted 5'-
nucleotidase, the ORF 17.20 and ORF 11.30 proteins, and those spots encoded by 
BG354905 and BG520944. 
 
4  Discussion 
 
To date few Trichinella ES proteins have been analysed in terms of their 
biological activity, due largely to problems in identifying individual proteins.  Yet 
these proteins function at the host-parasite interface and are probably crucial for 
successful parasitism both during the muscle stage and the intestinal stage during 
which a new infection is established in a host animal.  In the current study, we 
have successfully used 2-DE and proteomic analysis tools to identify ES proteins 
from the muscle larva, despite the absence of a genome-sequencing project for 
Trichinella.  Using PMF data from MALDI-TOF-MS and LC-MS/MS and a 
custom-assembled Trichinella sequence database, we assigned identities to 43 out 
of the 52 ES peptide spots analysed.  The majority of the ES proteins identified 
contain a predicted N-terminal signal peptide which supports the identifications 
and verifies that they are secretory proteins.  The use of 2-DE, coupled with 
protein identification, has also been informative with regard to determining the 
overall constitution and complexity of the ES.  The 43 peptide spots identified 
represented only 13 different proteins, indicating that several isoforms of many of 
the proteins were present.  There are a number of possible explanations for the 
different isoforms including post-translational modification, splice variants and 
protein processing.  For example, a large subset of T. spiralis ES proteins is 
glycosylated and differential glycosylation may account for some of the isoforms.  
The significance of differentially glycosylated variants may become more 
apparent once the roles of individual ES proteins have been elucidated.  For 
instance, it has been suggested that glycosylation may influence the activity of the 
TspSP-1 serine protease, as several N-glycosylation sites are found near the active 
site of the protein [17].   
 
The question of the function of the muscle larva ES proteins remains to be 
determined.  Undoubtedly, some of these proteins will play a role in the 
establishment or maintenance of the nurse cell and the observations that ES 
proteins localise to the surface of the parasite [36] and to the infected host nuclei 
[6, 7, 8]support this conclusion.  However, tyvelose-bearing ES glycoproteins 
may also play a significant role in the intestinal phase.  These glycoproteins 
originate in the muscle larva in a specialised secretory organ, the stichosome and 
are deposited in the intestinal epithelium during the establishment of a new 
infection [37, 38].  Furthermore, antibodies raised against Tyvelose are protective 
and result in rapid expulsion of parasites from the intestine on administration of a 
challenge infection [39, 40].  The application of proteomics in the present study 
has provided some much-needed basic data which will allow more focussed 
studies on the functions of individual Trichinella ES proteins to be carried out.  
These studies are in progress and will be the subject of future communications.  
The identification of the ES proteins is critical to understanding the host-parasite 
interaction and may have broader implications to the study of the fundamental 
biological mechanisms including those underlying maintenance of the 
differentiated state in mammalian cells.   
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Figure Legends 
Figure 1.  2-DE analysis T. spiralis muscle larvae ES proteins in the pH range 3-7 
and separated on 10-15% non-linear gradient polyacrylamide gels in the second 
dimension.  2-D gels stained with colloidal Coomassie blue G250 of ES proteins 
collected after 6 h (A), 20 h (B) or 40 h (C) of in vitro culture.  (D) Immunoblot of 
2-D gel of 40 h ES proteins, probed with the anti-tyvelose mAb 18H.   
 
Figure 2.  Coomassie-stained 2-D gel of 40 h ES proteins showing the positions of 
the 52 protein spots subjected to analysis by MS.  Spots were numbered and those 
identified are listed in Table 1.   
 
Figure 3.  Comparison of the 2-DE profiles of 40 h ES proteins that have been 
treated (+PNGase) or mock-treated (-PNGase) with PNGase F.  Spots identified 
by MALDI-TOF-MS following de-glycosylation: (a) secreted 5'-nucleotidase; (b) 
ORF 9.10; (c) 45 kDa antigen; (d) BG520575; (e) TspSp-1; (f) ORF 17.20.  The 
ORF 17.20 peptide spots that do not change position on treatment with PNGase 









Table 1. Identification of T. spiralis ES proteins identified by MALDI-TOF and LC-MS/MS  
 




Mr / pI1 
Observed







1 Serine protease AY02897
4 
48.0/6.33 54.0/5.44 24 4  274 
2 gp43 M95499 38.0/5.95 47.1/5.48 25 7 433 
3 ORF 9.10 U88241 47.6/5.60 48.5/4.94   440  
5 45kDa antigen U01847 31.0/4.76 47.1/4.21 17 5 326 
6 Unknown BG520944  57.0/3.75   362 
7 gp43 M95499 38.0/5.95 47.1/6.04 13 5  270 
8 Serine protease AY02897
4 
48.0/6.33 55.8/6.44 7 3 121 
9 Serine protease AY02897
4 
48.0/6.33 55.8/6.64   175 
10 Serine protease AY02897
4 
48.0/6.33 51.0/6.64 12 4  214 
11 Serine protease AY02897
4 
48.0/6.33 51.0/6.44   244 
12 Serine protease AY02897
4 
48.0/6.33 44.5/6.58 42 7 ND 
13 5'-nucleotidase AY12757
1 
62.0/6.13 62.8/6.86 15 6  1117 
14 Unknown BG520575  41.5/4.60 24 6 218 
15 Unknown BG520575  41.5/4.69 25 10 263 
16 ORF 9.10 U88241 47.6/5.60 48.5/4.86 32 10 404 
17 ORF 9.10 U88241 47.6/5.60 36.4/4.94 38 5 392 
18 ORF 9.10 U88241 47.6/5.60 35.0/5.36   423 
19 ORF 9.10 U88241 47.6/5.60 32.5/5.36 21 5 405 
20 ORF 9.10 U88241 47.6/5.60 33.2/5.55 35 5 336 
21 ORF 9.10 U88241 47.6/5.60 33.2/5.78 35 6 543 
26 Serine protease AY02897
4 
48.0/6.33 54.0/5.14   163 
27 45kDa antigen U01847 31.0/4.76 38.0/3.92   87 
28 45kDa antigen U01847 31.0/4.76 38.0/4.00 14 6 106 
29 Unknown BQ540916  35.0/3.89 22 5 496 
30 Unknown BQ540916  35.0/4.00 27 6 417 
31 Serine protease AY02897
4 
48.0/6.33 65.0/5.64   175 
32 Serine protease AY02897
4 
48.0/6.33 69.0/5.83   210 
33 Serine protease AY02897
4 
48.0/6.33 65.0/5.83   211 
34 Serine protease AY02897
4 
48.0/6.33 65.0/6.01   201 
35 Serine protease AY02897
4 
48.0/6.33 47.1/5.69   105 
36 Unknown BQ542714  28.2/5.00   239 
38 Unknown BG354905  31.0/6.67   214 
39 ORF 17.20 U88239 19.5/6.13 24.6/4.92   211 
40 ORF 17.20 U88239 19.5/6.13 24.6/5.33 47 9 338 
41 ORF 17.20 U88239 19.5/6.13 22.5/5.42   179 
42 ORF 17.20 U88239 19.5/6.13 22.5/5.89 40 16 208 
43 ORF 17.20 U88239 19.5/6.13 22.5/6.39 37 9 320 
45 Unknown BG353021 15.7/6.283 18.2/6.10   256 
46 ORF 11.30 U88238 12.7/4.17 15.0/3.44   397 
49 Unknown BG353021 15.7/6.283 16.0/6.06   257 
50 Unknown BG353021 15.7/6.283 18.2/6.89 57 7 387 
51 Unknown BG353717 15.7/6.283 16.3/6.89 39 6 239 
52 Unknown BG353021 15.7/6.283 18.2/5.36   310 
 
1 Theoretical molecular mass (kDa) and pI 
2 A MOWSE score of >70 was used to assign identity to a protein analysed by LC-MS/MS 
3 Molecular mass and pI of predicted protein encoded on contig TS01176  
 
